Chemicals & Pharmaceuticals

3A-Strategy's Chemicals & Pharmaceuticals practice supports a growing number of organisations in the industry throughout the world.

Chemicals and pharmaceutical organisations worldwide have undergone fundamental change - from mergers and acquisitions and strategic partnerships to exploration of new foreign markets and increasing regulatory scrutiny. To help ensure success and growth in the marketplace, organisations must develop creative strategies to become and remain profitable.

We work with a large proportion of Europe's chemical and pharmaceuticals sectors, from Germany's largest organisations, medium to small companies and subsidiaries of overseas-owned organisations.

Our understanding of the industry is both current and forward looking as a result of our global experience, knowledge sharing, industry training and the use of professionals who have direct experience in the chemical and pharmaceutical sector.

We assist clients across a range of important business issues:

Globalisation and domestic rationalisation

shaping manufacturing strategy to compete successfully in local and global markets.

Cost reduction

through from raw material costs to R&D expenditures.

Business rationalisation

shedding non-core and underperforming assets and product lines from business case to completion.

e-Business

leading and fast following adoption of B2B exchange alliances.

Innovation and research

improving and accelerating the product development and approval pipeline, and capitalising on advances in proteomics, pharmacogenomics and bioinformatics.

Intellectual property

post patent expiration and product life cycle strategies.

Productivity, capacity and outsourcing

decisions concerning outsourcing to toll manufacturers.

Inventory management

inventory strategy.

Risk management

integrating an enterprise wide portfolio with corporate strategy to enhance earnings potential.

Cash flow and finance

for funding growth, acquisitions and new market plays.

Emissions and environment

helping to contain stewardship responsibilities and compliance costs whilst enhancing credits.